Evidence map›Paper›PMID 38169447›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2024

PARting Neuroinflammation with Protease-Activated Receptor 2 Pepducins.

Isobel A Scarisbrick

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Isobel A ScarisbrickCenter for Regenerative Biotherapeutics, Department of Physical Medicine and Rehabilitation, and Department of Physiology and Biomedical Engineering, Mayo Clinic Graduate School of Biomedical Sciences, Regenerative Sciences, Rochester, Minnesota Scarisbrick.Isobel@mayo.edu.ORCID https://orcid.org/0000-0003-2395-589X

Funding

Targeting Protease Activated Receptor 1 for Repair of the Injured Spinal CordR01NS120877 · NINDS · MAYO CLINIC ROCHESTER · PI SCARISBRICK, ISOBEL A · 2021 to 2024
$1.9M
Regulatory Action of Protease Activated Receptor 1 in Myelin ProductionR21NS107946 · NINDS · MAYO CLINIC ROCHESTER · PI SCARISBRICK, ISOBEL A · 2019 to 2019
$437k
NINDS NIH HHS R01 NS120877NINDS NIH HHS R21 NS107946
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neuroinflammatory DiseasesReceptor, PAR-2HumansReceptors, G-Protein-CoupledSignal TransductionReceptor, PAR-2Receptors, G-Protein-Coupled

Identifiers

PMID38169447
PMCPMC12164717

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.